Detalhe da pesquisa
1.
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
N Engl J Med
; 386(20): 1910-1921, 2022 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320659
2.
Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.
Diabetes Technol Ther
; 24(2): 84-92, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34515521
3.
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.
Nat Med
; 28(10): 2092-2099, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36192552
4.
Clinical Impact of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Uncontrolled Type 2 Diabetes and Very High Baseline HbA1c: The FREEDOM-1 HBL (High Baseline) Study.
Diabetes Care
; 41(3): 613-619, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29301824
5.
A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II.
Diabetes Technol Ther
; 20(3): 197-206, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29381090
6.
Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.
Nat Med
; 29(11): 2959, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36932248
7.
Glycemic Effect and Safety of a Systemic, Partial Glucokinase Activator, PF-04937319, in Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin-A Randomized, Crossover, Active-Controlled Study.
Clin Pharmacol Drug Dev
; 5(6): 517-527, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27870481
8.
Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial.
Am J Med
; 126(2): 141-9, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23218892